Page 3 - மேற்பரப்பு புற்றுநோயியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மேற்பரப்பு புற்றுநோயியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மேற்பரப்பு புற்றுநோயியல் Today - Breaking & Trending Today

Biliary Tract Cancers (BTC) Market Size Anticipated to Soar During the Forecast Period 2021-30 at a CAGR of 11.69% in the 7MM, Projects DelveInsight


Erdafitinib (Janssen Research and Development).
The anticipated launch of targeted therapies including potential FGFR gene fusions and somatic mutations in IDH 1/2 in iCCA, PRKACA or PRKACB gene fusions in pCCA, and ELF3 mutations in dCCA/ampullary carcinoma shall push the growth of the BTC market size in the offing. 
Further, an increase in the BTC incidence, increment in healthcare spending, extensive R&D along better awareness of cancer is expected to give the BTC market size growth a much-needed momentum. 
Get in touch for a holistic view of the
The BTC market report also covers the market of Cholangiocarcinoma including (Intrahepatic and Extrahepatic), Gallbladder, treatment practice/algorithm, market drivers, market barriers, and unmet medical needs that help clients curate the best of the opportunities and assess the market s underlying potential, and plans strategically to tackle market risks. ....

United States , United Kingdom , Innovent Biologics , Roche Ipatasertib , Prnewswire Delveinsight , Chia Tai Tianqing , Derazantinib Basilea Pharmaceutica , Astellas Pharma Talazoparib , Regorafenib Bayer , Cholangiocarcinoma Intrahepatic , Shruti Thakur , Fite Biopharma , Basilea Pharmaceutica , Dohme Keytruda , Bristol Myers Squibb Opdivo , Dohme Lynparza , Entrectinib Hoffmann , Extrahepatic Cholangiocarcinoma , Novartis Lutathera , Janssen Research , Micurx Pharmaceuticals , Aeterna Zentaris , Signalrx Pharmaceuticals , Zai Lab Shanghai , Janssen Research Development Niraparib , Innovation Pharmaceuticals ,

Surface Oncology Named a 2021 Best Places to Work Company by Boston Business Journal


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Surface Oncology Named a 2021 Best Places to Work Company by Boston Business Journal
Surface Oncology, Inc.April 19, 2021 GMT
CAMBRIDGE, Mass., April 19, 2021 (GLOBE NEWSWIRE) Surface Oncology, a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that it has been recognized by the
Boston Business Journal as one of the Best Places to Work in 2021. This exclusive distinction features Massachusetts companies that have built outstanding work environments.
ADVERTISEMENT
“This honor is a credit to every member of the Surface team. We strive to foster an environment with a strong sense of community and shared commitment to learning and working together to develop life-changing therapies for patients with cancer,” said Rob Ross, M.D., chief executive officer at Surface Oncology. ....

United States , United Kingdom , Rob Ross , Chris Railey , Boston Business Journal , Best Places , Surface Oncology , North America , Pharmaceutical Manufacturing , Health Care Industry , Globe Newswire , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , கொள்ளை ரோஸ் , போஸ்டன் வணிக இதழ் , சிறந்தது இடங்கள் , மேற்பரப்பு புற்றுநோயியல் , வடக்கு அமெரிக்கா , மருந்து உற்பத்தி , ஆரோக்கியம் பராமரிப்பு தொழில் ,